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Abstract. 
Background: Tuberculosis remains a major health problem in developing countries especially with 
the emergence of multidrug resistant strains. Mendelian Susceptibility 
(MSMD) is a rare disorder with impaired immunity against mycobacterial pathogens. Reported 
MSMD etiologies highlight the crucial role of the Interferon gamma /Interleukin 12 (IFN
axis and the phagocyte respiratory burst axis. 
Purpose: Screen patients with possible presentations for MSMD.
Methods: Patients with disseminated BCG infection following vaccination,
infections or recurrent tuberculosis inf
Clinic  at  Cairo  University  Specialized  Pediatric  Hospital,  Egypt  and  immune  and  genetic 
laboratory investigations were conducted at Human Genetic of Infectious Diseases laboratory in 
Necker  Medical  School,  France  from  2005
mutations in the eight previously identified MSMD
Results: Nine cases from eight (unrelated) kindreds were evaluated in detail. We detected a high 
level of IFN- in plasma in one patient. Through Sanger sequencing, a homozygous mutation in the 
IFNGR1 gene at position 485 corresponding to an amino acid change from serine to phenylalanine 
(S485F), was detected in this patient. 
Conclusion: We report the first identified case
particular a new IFNGR1 mutation underlying IFN
need to be explored further. These findings have implications regarding the compulsory Bacillus 
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Tuberculosis remains a major health problem in developing countries especially with 
the emergence of multidrug resistant strains. Mendelian Susceptibility to Mycobacterial Disease 
(MSMD) is a rare disorder with impaired immunity against mycobacterial pathogens. Reported 
MSMD etiologies highlight the crucial role of the Interferon gamma /Interleukin 12 (IFN
axis and the phagocyte respiratory burst axis. 
Screen patients with possible presentations for MSMD.
Patients with disseminated BCG infection following vaccination,
infections or recurrent tuberculosis infections were recruited from the Primary Immune Deficiency 
Clinic  at  Cairo  University  Specialized  Pediatric  Hospital,  Egypt  and  immune  and  genetic 
laboratory investigations were conducted at Human Genetic of Infectious Diseases laboratory in 
School,  France  from  2005-2009.  IFN- level  in  patient’s  plasma  as  well  as 
mutations in the eight previously identified MSMD-causing genes were explored. 
Nine cases from eight (unrelated) kindreds were evaluated in detail. We detected a high 
in plasma in one patient. Through Sanger sequencing, a homozygous mutation in the 
gene at position 485 corresponding to an amino acid change from serine to phenylalanine 
(S485F), was detected in this patient. 
st identified case of MSMD among Egyptian patients, including in 
particular a new IFNGR1 mutation underlying IFN-R1 deficiency. The eight remaining patients 
need to be explored further. These findings have implications regarding the compulsory Bacillus 
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
n Egyptian Children
,  Jacqueline  Feinberg
3,4,  Jean-Laurent 
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, 
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la  Santé et de la 
Primary Immunodeficiency Clinic, Department of Pediatrics, 
an  Open  Access  article  distributed  under  the  terms  of  the  Creative  Commons  Attribution  License
which permits unrestricted use, distribution, and reproduction in any medium, 
Tuberculosis remains a major health problem in developing countries especially with 
to Mycobacterial Disease 
(MSMD) is a rare disorder with impaired immunity against mycobacterial pathogens. Reported 
MSMD etiologies highlight the crucial role of the Interferon gamma /Interleukin 12 (IFN-/ IL-12) 
Patients with disseminated BCG infection following vaccination, atypical mycobacterial 
ections were recruited from the Primary Immune Deficiency 
Clinic  at  Cairo  University  Specialized  Pediatric  Hospital,  Egypt  and  immune  and  genetic 
laboratory investigations were conducted at Human Genetic of Infectious Diseases laboratory in 
level  in  patient’s  plasma  as  well  as 
causing genes were explored. 
Nine cases from eight (unrelated) kindreds were evaluated in detail. We detected a high 
in plasma in one patient. Through Sanger sequencing, a homozygous mutation in the 
gene at position 485 corresponding to an amino acid change from serine to phenylalanine 
of MSMD among Egyptian patients, including in 
R1 deficiency. The eight remaining patients 
need to be explored further. These findings have implications regarding the compulsory Bacillus Mediterr J Hematol Infect Dis 2012; 4; Open Journal System 
Calmette Guerin vaccination policy in Egypt, especially given the high consanguinity rate.
Introduction.  Tuberculosis  (TB)  still  constitutes  a 
leading cause of mortality and morbidity especially in 
developing  countries.  Patients  with  Mendelian 
Susceptibility  to  Mycobacterial  Disease  (MSMD) 
present clinical disease caused by weakly pathogenic 
mycobacteria such as Bacillus Calmette-Guérin (BCG) 
vaccines  and/or  nontuberculous  environmental 
mycobacteria in otherwise healthy individuals.
1 These 
patients  are  also  vulnerable  to  Mycobacterium
tuberculosis.
2,3 MSMD  is  generally  attributed  to 
defects  in  the  Interleukin  12-Interferon  gamma  (IL-
12/IFN-) pathways. IFN- immunity is important for 
control of intracellular organisms like Mycobacterium
tuberculosis,  atypical  mycobacteria,  BCG,  and 
Salmonella.  Upon  ingestion  of  these  intracellular 
organisms, the macrophage secretes IL-12, which binds 
to its receptor (IL12RB1 and IL12RB2) present at the 
surface of T and NK cells, leading ultimately to IFN-γ 
secretion by these cells. IFN-γ then binds its receptor 
(composed  of  IFNGR1  and  IFNGR2)  on  the 
macrophage and activates genes including IL-12 and 
the respiratory burst NADPH oxidase which will allow 
the macrophage to kill the ingested bacteria.
4 IFNGR1
and  IFNGR2,  STAT1,  IL12B and  IL12RB1 are  all 
identified  players  that  are  involved  in  interleukin 
12/23-dependent  IFN- mediated  immunity.  Human 
mutations in IFNGR1, IFNGR2 and STAT1 impair the 
cellular response to IFN-, whereas mutations in IL12B
and  IL12RB1 impair  the  IL-12/23-dependent 
production  of  IFN-.
5,6 More  recently,  human 
mutations  in  IRF8,  an  interferon  regulatory  factor 
inducible  by  IFN-γ,  impair  IL-12  secretion  by 
monocytes  and  dendritic  cells.
7 NEMO and  CYBB
mutations are responsible of X-linked MSMD.
6,8 We 
have studied immunologically and genetically patients 
with  disseminated  BCG  infection  following 
vaccination, atypical  mycobacterial  infections  or 
recurrent tuberculosis infections collected in  Primary 
Immune  Deficiency  Clinic  at  Cairo  University 
Specialized  Pediatric  Hospital,  in  Egypt  from  2005-
2009.
Patients and Methods. Clinical cases were recruited 
from  Primary  Immune  Deficiency  Clinic  at  Cairo 
University Specialized Pediatric Hospital, in Egypt, in 
the period 2005 from through 2009.  Immunological 
and  genetic  investigations  were  conducted  at  the 
Human  Genetic  of  Infectious  Diseases  laboratory  in 
Necker  Medical  School,  France.  The  study  was 
approved by the institutional review board (IRB) and 
informed consents were obtained from each patient or 
the patient’s family. The IRB was also consulted and 
the study approved in France. Children presenting with 
the  following  manifestations  were  included:  BCG 
infection  –culture  identification  of  Mycobacterium 
bovis BCG  strain,  disseminated  BCG  infection 
following vaccination (BCG-osis) inferred on clinical, 
radiologic  findings,  atypical  mycobacterial  infections 
in immune competent children, mycobacterial disease 
resistant to therapy (disease that does not respond to 
two  or  more  standard  anti-TB  drugs)  and 
microbiological evidence of Salmonella. Patients with 
acquired  or  inherited  disorders  known  to  cause 
disseminated BCG infection, such as Severe Combined 
Immune  Deficiency  or  T  cell  defects,  chronic 
granulomatous disease, Di George syndrome or AIDS 
were  excluded  of  this  study.  All  patients  were 
subjected  to  thorough  history  taking  and  systematic 
clinical examination with emphasis on consanguinity, 
family  history,  vaccination  history  (age,  site,  route, 
complications), infection history, system review (e.g. 
pulmonary, gastrointestinal manifestations), tuberculin 
test, treatment used, duration, outcome. Immunological 
assessment included complete blood counts, nitro blue 
tetrazolium reduction test, T, B and NK cell subsets by 
flow  cytometry  (using  FACSE  Pics,  coulter)  CD3, 
CD4,  CD8,  CD56,  CD19,  immunoglobulins  (Radio 
immunoassay),  and  human  immunodeficiency  virus 
serology (HIV) status. IFN- in plasma was measured 
by enzyme-linked immunosorbent assay (ELISA) [9]. 
Genomic  DNA  was  extracted  from  whole  blood  as 
described  previously.
10 The  coding  and  flanking 
sequence of 8 genes known to predispose to MSMD 
were  amplified  and  sequenced  with  an  ABI  3130x 
sequencer. The pairs of primers and PCR conditions 
are available upon request. Polymorphism phenotyping 
(PolyPhen) was used to predict the possible impact of 
an  amino  acid  substitution  on  the  structure  and  the 
function of a human protein.
Results.  Fifteen  children  with  disseminated 
mycobacterial infection were initially included. Six of 
them were excluded after their immunological workup 
analysis  identified  Primary  Immunodeficiency 
disorders  including  Severe  Combined 
Immunodeficiency (n=5) and Chronic Granulomatous 
Disease (n=1). We investigated the eligible case series 
which included five males and four females. The mean 
patient  age  was  3.5  years  ±  4.9.  The  mean  age  of 
presentation  was  3.2  months.  Consanguinity  was 
positive  in  six  out  of  nine  cases  (first  degree). Two 
families had history of previous sibling deaths (due to 
similar conditions) and one mother had history of two 
previous  abortions  (Table  1).  All  patients  received Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
BCG  vaccine  during  the  first  two  months  of  life 
(except  number  9  whose  vaccination  was  withheld 
because  of  sibling  death  (due  to  mycobacterial 
diseases).  The  vaccine  was  administered  intra-
dermally,  in  the  upper  left  arm  by  registered  health 
workers according to the national vaccination policy. 
Seven  out  of  the  nine  cases  reported  local 
complications  related  to  BCG  in  the  form  of  poor 
healing,  ulceration,  abscess  formation,  skin 
tuberculosis  (lupus  vulgaris-like)  and/or  local 
lymphadenitis. Clinical presentations included for case
1,  lymphadenopathy  caused  by  an  atypical 
mycobacterial  (Mycobacterium  fortuitum)  (Table  1), 
for  case  2,  recurrent  bloody  diarrhea  caused  by 
Salmonella  enteritidis infection,  case  3  had 
mycobacterial  osteomyelitis  fistulizing  to  bone,  and 
case 8 had renal tuberculous granulomata evidenced by 
renal biopsy. Presentations and demographic data are 
shown in Table 1. Generalized lymphadenopathy was 
present  in  five  cases  (n=5)  whereas  the  chest  was 
involved  in  four  cases  (n=4).  All  patients  received 
antituberculous  medications  in  the  form  of  triple 
therapy  including  Isoniazide,  Rifampicin, 
Pyrazinamide  (with  exchange  of  Pyrazinamide  with 
Streptomycin in cases of BCGosis) and or quadruple 
therapy (cases number 3 and 8) (Ethambutol/ Dalacin) 
with  good response in five cases. Treatment was set 
initially for six months and extended according to the 
progress of cases individually. As for outcome, three 
patients (cases   # 3, 4  and 6) died  of complications 
(fulminant  Pneumoniae),  one  of  patients  remains 
symptomatic with lymphadenopathy that is progressing 
despite  therapy  (case  #  2)  and  five  patients  cleared 
their infections after prolonged therapy .
We measured IFN- in plasma of nine patients and 
we found a high IFN- plasma levels (813 pg/ml) in 
one  patient  (patient  #  3)  highly  suggestive  of  a 
complete  IFNGR  deficiency.  The  7  coding  and 
flanking intron sequences of IFNGR1 were amplified 
and sequenced. We identified a homozygous mutation 
in exon 7 of IFNGR1 gene leading to the replacement 
of a serine at amino acid position 485 to phenylalanine 
(S485F),  probably responsible for  complete IFNGR1 
deficiency  and  the  MSMD  syndrome.  Unfortunately, 
this  patient  died  and  we do  not  dispose  the  cells  to 
characterize the impact of this variation.  Indeed, the 
variation has not previously been reported in any SNP 
database, the change is non-conservative and affects an 
amino-acid  relatively  conserved  among  species.  We 
carried out bioinformatics analysis by PolyPhen; this 
method predicted that S485F is “probably damaging” 
with a score of 0.99 of protein structure. Moreover the 
C-terminal  part  of  IFNGR1  had  been  proved  to  be 
essential for  the  docking of  STAT1 upon activation.  
No other mutations have been identified in the seven 
other  genes  of  MSMD  in  this  patient.    Indeed,  the 
combination  of  high  IFN- in  plasma  and  the 
mutation’s  impact  predicted  are  sufficient  for  the 
diagnosis.  Eight  other patients  included in  this  work 
presented  wild  type  sequences in  the  exons  of  eight 
genes involved in MSMD. 
Discussion. This study reports the first identified case 
of MSMD among Egyptian children. Other colleagues 
have previously studied the association of interferon-
gamma  (IFN-γ)  and  interleukin-10  (IL-10)  single 
nucleotide  polymorphisms  with  tuberculous  infection 
and  post-BCG  lymphadenitis  in  Egyptian  children 
revealing that low producer IFN-γ +874 A/A genotype 
was associated with post-BCG lymphadenitis and TB 
disease especially in younger children below 5 years.
11
Older  studies  have  looked  into  the  relation  between 
atypical  mycobacterial  infections  and  mammalian 
tuberculosis  perhaps  describing  an  unrecognized 
MSMD back then.
12
In our series, the case with IFN-γR1 deficiency was 
BCG vaccinated at seven weeks of age, manifested at 
four months and suffered extensive spreading lesions 
over  the  course  of  several  years  highlighting  the 
prolonged  course  patients  may  suffer.  She  was 
diagnosed  and  treated  as  a  case  of  extensive 
tuberculosis. The early age of presentation necessitates 
increasing  physicians’  awareness  to  initiate  early 
treatment  and requires vigilance for  more aggressive 
therapy if required.
Consanguinity was positive in six out of nine cases 
in  the  series,  high  rates  of  consanguinity  and  in  –
breeding may lead to occurrence of recessive disorders 
at  higher  rates  than  other  populations.  The  average 
consanguinity rate in Egypt which was estimated to be 
28.96% in the eighties has risen recently to thirty-forty 
percent  with  an  average  inbreeding  coefficient  of 
0.010.
13,14 Interestingly, the first patient with MSMD 
was  reported  in  Tunisia,  a  country  with  a  similar 
pattern  of  inbreeding  and  consanguinity.
15 Since 
MSMD  disorders  may  be  transmitted  either  in  a 
recessive  or  dominant  manner,  there  is  a  growing 
potential for the existence of recessive forms. A study 
of  inbred  consanguineous  populations  from  North 
African  countries  recommended  investigating  IL-
12RB1 deficiency in patients with severe tuberculosis 
whether or not adverse effects of BCG vaccination or 
atypical mycobacteriosis were observed.
16 One of the 
cases  suffered  recurrent  attacks  of  Salmonella 
enteritidis,  a  finding  reported  in  several  other 
studies.
17,18
The  remaining  eight  cases  might  have  had 
unrecognized  defects  of  NADPH  axis  as  it  is  also 
important for the control of mycobacterial infections. 
More  genetic  mutations  of  IFN-γ pathways  areMediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 1. Characteristics of the study group
Case number 1 2 3 4 5 6 7 8 9
Age (Year) 0.5 4 16 1.5 2 1.5 1 5 0.3
Sex (M/F) F M F M M F M F M
Consanguinity - + + + - + - + +
Similar conditions -
2 sib 
deaths
2 maternal 
abortions - - 2 sib 
deaths - - 3 sib 
deaths
Presentation BCG
osis
BCG
osis
Diarrhoe
GLN
BCGosis
Fistulizing 
bone lesions
GLN
Lung
BCGosis
Diarrhoea
FTT
GLN
Lung
Atypical 
mycobacteri
a GLN
BCGosis
GLN
Lung
FTT
BCGosis
BCGosis
GLN
Renal 
granulom-
as
Lung
Age of onset
(month)
5 4 2 4 4 2 3 3 4
Mycobacterial 
strain
BCG BCG BCG BCG NTM BCG BCG BCG TB
Viral infections - - - - - - - -
Salmonella - + - - - - - -
Vaccination + + + + + + + + -
Response to 
therapy G R R R G R G G G
Outcome AW AS D D AW D AW AW AW
Identified 
mutations - - IFNGR1 - - - - - -
M=male,  F=female,  +  =positive,  – =negative,  BCGosis (disseminated  BCG  infection  following  vaccination),  GLN=Generalized 
lymphadenopathy,  FTT=Failure  to  thrive,  TB=tuberculous,  NTM=Nontuberculous  mycobacteria  G=Good,  R=Resistant,  AW=Alive  and 
well, AS=Alive and symptomatic, D=Deceased, IFNGR1 =Interferon gamma receptor 1 deficiency
discovered every day helping to elaborate their role in 
disease causation and the magnitude of the problem. 
MSMD  exists  in  Egyptian  children  and  needs  to  be 
explored  further.  The  remaining  cases  will  undergo 
combination of exome-sequencing and linkage analysis 
to elucidate the genetic disease.
19,20
Conclusion.  MSMD  exists  in  Egyptian  children; 
finding  should  have  implications  on  the  compulsory 
BCG  vaccination  policy  especially  with  the  high 
consanguinity  rates,  deferring  vaccination  till  further 
evaluation occurs.
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